Literature DB >> 6778510

Crystallization and properties of staphylococcal leukocidin.

M Noda, T Hirayama, I Kato, F Matsuda.   

Abstract

Two components (F and S) of leukocidin were isolated and purified from broth culture of V8 strain of Staphylococcus aureus. There was loss of leukocidin activity during the separation, which was regained by mixing the components. Each component was apparently homogeneous by several criteria. The F and S components were crystallized (by salting out with saturated (NH4)2SO4 at pH 7.0) in the form of square plates and very fine needles, respectively, and the molecular weights of the components were approx. 32 000 and 31 000, respectively. The isoelectric points of the F and S components were pH 9.08 and 9.39, respectively. No detectable half-cystine and free sulfhydryl groups were found in either component. Amino-terminal amino acid analysis of both components showed a single alanine residue. The F and S components of leukocidin acted synergistically on granulocytes from rabbit peripheral blood and a minimum lethal dose of 0.5 ng of each component destroyed all granulocytes at a concentration of 10(6) cells/20 microliter.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6778510     DOI: 10.1016/0304-4165(80)90035-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

1.  Stochastic assembly of two-component staphylococcal gamma-hemolysin into heteroheptameric transmembrane pores with alternate subunit arrangements in ratios of 3:4 and 4:3.

Authors:  Noriko Sugawara-Tomita; Toshio Tomita; Yoshiyuki Kamio
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

Review 2.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

Review 3.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

4.  Use of 51Cr release to measure the cytotoxic effects of staphylococcal leukocidin and toxin neutralization on bovine leukocytes.

Authors:  D A Loeffler; K A Schat; N L Norcross
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

5.  Sequencing of leucocidin R from Staphylococcus aureus P83 suggests that staphylococcal leucocidins and gamma-hemolysin are members of a single, two-component family of toxins.

Authors:  G Supersac; G Prevost; Y Piemont
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

6.  Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation.

Authors:  D A Colin; I Mazurier; S Sire; V Finck-Barbançon
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Mode of action of staphylococcal leukocidin: effects of the S and F components on the activities of membrane-associated enzymes of rabbit polymorphonuclear leukocytes.

Authors:  M Noda; I Kato; T Hirayama; F Matsuda
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

8.  Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities.

Authors:  G Prévost; B Cribier; P Couppié; P Petiau; G Supersac; V Finck-Barbançon; H Monteil; Y Piemont
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Characterization of Clostridium perfringens iota-toxin genes and expression in Escherichia coli.

Authors:  S Perelle; M Gibert; P Boquet; M R Popoff
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

10.  Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain.

Authors:  M R Popoff; E J Rubin; D M Gill; P Boquet
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.